01 Mar 2017 Last updated at 16:55 ET

Search company or market
Search company or market:
Refresh this page Launch Marketwatch ticker
 London | NYSE | Nasdaq | Paris | Frankfurt
Search share prices by name or symbol*:
* In London, New York, Paris, Frankfurt and on Nasdaq.

 
Pharmacyclics Inc.
Pharmacyclics Inc. intraday chart
 Previous close value
*All charts show local time Select time span for charts: 
price
change
%
52 wk-h
52 wk-l
  261.25
0.00
0.00
261.25 261.25

Indexes
value
change
%
5904.03
+78.59
+1.35
21115.55
+303.31
+1.46
2395.96
+32.32
+1.37

Market reports
London
Wall Street
Asia
Top 10 winners
value
change
%
Amicus Therapeutics Inc.
7.60
+1.11
+17.10
Rigel Pharmaceuticals Inc.
2.85
+0.40
+16.33
HTGM
3.17
+0.44
+16.12
Office Depot Inc.
4.83
+0.66
+15.83
Kite Pharma, Inc.
79.62
+8.85
+12.51
Builders Firstsource Inc.
14.54
+1.60
+12.36
Biocryst Pharmaceuticals Inc.
6.86
+0.62
+9.94
Century Aluminum Company
15.39
+1.31
+9.27
Infinity Pharmaceuticals Inc.
3.00
+0.22
+7.91
Gogo Inc
11.41
+0.81
+7.64
Top 10 losers
value
change
%
Impax Laboratories Inc.
9.30
-4.95
-34.74
Etsy Inc Usd0.001
10.69
-1.43
-11.80
Dryships Inc.
1.91
-0.15
-7.28
Microbot Medical Inc
6.30
-0.49
-7.22
LIFE
3.75
-0.25
-6.25
Endo International Plc
12.82
-0.83
-6.08
Zosano Pharma Corporation
2.56
-0.12
-4.48
Velocityshares Daily 2x Vix Short Term Etn
4.64
-0.21
-4.33
Jaguar Animal Health, Inc.
1.14
-0.05
-4.20
Sunpower Corp. Class A
8.40
-0.36
-4.11
Winners and Losers are drawn from Nasdaq equities with a daily trade volume > 2,000,000 and share price > $1

All market data carried by BBC News is provided by DigitalLook.com. The data is for your general information and enjoys indicative status only. Neither the BBC nor Digital Look accept any responsibility for its accuracy or for any use to which it may be put. All share prices and market indexes delayed at least 15 minutes. 52 week high and low values are calculated from close price data. Click here for terms and conditions

Features & Analysis

Copyright © 2016 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.